Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction

Obesity

Volumn 25, Issue 8, 2017, Pages 1313-1316

  Simon, Tracey G ^a   Bamira, Daniel G ^a   Chung, Raymond T ^a   Weiner, Rory B ^a   Corey, Kathleen E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; CARDIOVASCULAR FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; E A RATIO; E WAVE; ELECTIVE SURGERY; FEMALE; HEART DISEASE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; LATERAL E; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RETROSPECTIVE STUDY; SEPTAL E; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; BLOOD PRESSURE; COMPLICATION; DIASTOLE; ECHOCARDIOGRAPHY; HEART; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; CREATININE; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; GLYCATED HEMOGLOBIN A; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 85025610128     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21879     Document Type: Article

References (14)

1. VanWagner LB, Wilcox JE, Colangelo LA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 2015;62:773-783.
2. Targher G, Bertolini L, Rodella S, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008;16:1394-1399.
3. Pacifico L, Di Martino M, De Merulis A, et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014;59:461-470.
4. Karabay CY, Kocabay G, Kalayci A, et al. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. Eur J Gastroenterol Hepatol 2014;26:325-331.
5. Petta S, Craxi A. Epicardial fat in patients with non-alcoholic fatty liver disease. J Hepatol 2015;62:1215. doi:10.1016/j.jhep.2015.01.012
6. Cuspidi C, Giudici V, Negri F, et al. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height (2.7). J Hypertens 2009;27:2465-2471.
7. Pritchett AM, Jacobsen SJ, Mahoney DW, et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003;41:1036-1043.
8. Beinart R, Boyko V, Schwammenthal E, et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol 2004;44:327-334.
9. Meris A, Amigoni M, Uno H, et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. Eur Heart J 2009;30:56-65.
10. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2016;17:1321-1360.
11. Fotbolcu H, Yakar T, Duman D, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010;17:457-463.
12. Bonci E, Chiesa C, Versacci P, et al. Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: a systematic review and meta-analysis. Biomed Res Int 2015;2015:213737. doi:10.1155/2015/213737
13. Lautamaki R, Borra R, Iozzo P, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006;291:E282-E290.
14. Kane GC, Karon BL, Mahoney DW, et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011;306:856-863.